Clinical practice guideline for the management of lipids in adults with diabetic kidney disease: abbreviated summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2024

BMC Nephrol. 2024 Jul 6;25(1):216. doi: 10.1186/s12882-024-03664-1.

Abstract

The contribution of chronic kidney disease (CKD) towards the risk of developing cardiovascular disease (CVD) is magnified with co-existing type 1 or type 2 diabetes. Lipids are a modifiable risk factor and good lipid management offers improved outcomes for people with diabetic kidney disease (DKD).The primary purpose of this guideline, written by the Association of British Clinical Diabetologists (ABCD) and UK Kidney Association (UKKA) working group, is to provide practical recommendations on lipid management for members of the multidisciplinary team involved in the care of adults with DKD.

Keywords: Chronic kidney disease; Diabetes; Diabetic kidney disease; Lipid management; Lipids; Nephropathy.

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • Adult
  • Cardiovascular Diseases / therapy
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / therapy
  • Diabetic Nephropathies* / therapy
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Lipids / blood
  • United Kingdom / epidemiology

Substances

  • Lipids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors